Laxmi Organic Industries Ltd Share Price – NSE /  BSE

Chemicals, Small Cap

The headline equity benchmarks pared all early losses and traded with modest gains in morning trade. The Nifty traded above the 23,200 level after hitting the day's low of 23,090.65 in early trade. IT shares extended gains for the second consecutive trading session. Trading could be volatile due to weekly F&O series expiry today.

At 10:30 IST, the barometer index, the S&P BSE Sensex rose 235.91 points or 0.31% to 76,640.90. The Nifty 50 index added 82 points or 0.35% to 23,237.35.

The broader market outperformed the frontline indices. The S&P BSE Mid-Cap index jumped 1.96% and the S&P BSE Small-Cap index rallied 1.24%.

The market breadth was strong. On the BSE, 2,411 shares rose and 1,094 shares fell. A total of 174 shares were unchanged.

Politics:

The JD(U) on Wednesday sacked its Manipur unit president, Ksh. Biren Singh, in an effort to quell growing speculation about its ties with the BJP. Party’s national spokesperson Rajiv Ranjan told the media Singh’s removal was due to indiscipline and asserted that the party would continue to support the BJP-led government in the northeastern state. Ranjan affirmed that the JD(U) remains committed to supporting the BJP-led NDA, not just in Manipur but across the country. Ranjan’s remark came shorty after Ksh Biren Singh claimed that the party had withdrawn support to the BJP-led Biren Singh government and informed its decision to governor Ajay Kumar Bhalla. The state unit chief had also claimed that the lone JDU MLA in the state, Md Abdul Nasir, will sit in the opposition benches.

Result Today:

UltraTech Cement (up 1.70%), Dr Reddy's Laboratories (down 0.77%), Hindustan Petroleum Corporation (down 1.18%), Indus Towers (up 2.06%), United Spirits (up 2.03%), Adani Energy Solutions (up 0.23%), Adani Green Energy (up 1.32%), Amber Enterprises India (up 10.35%), Capri Global Capital (up 1.34%), Cyient (up 1.74%), Greaves Cotton (up 2.88%), Indian Energy Exchange (down 0.15%), KFin Technologies (up 4.99%), Mankind Pharma (up 1.33%), Mphasis (up 3.44%), Nippon Life India Asset Management (up 2.64%), Senores Pharmaceuticals (up 2.52%), Sona BLW Precision Forgings (up 2.05%), Spandana Sphoorty Financial (down 0.08%), Suryoday Small Finance Bank (up 1.82%), Syngene International (down 0.19%), Tejas Networks (up 1.40%), Thyrocare Technologies (up 1.87%), Ujjivan Small Finance Bank (up 0.84%), V2 Retail (up 3.26%) and Zee Entertainment Enterprises (up 1.44%) will announce their quarterly later today.

New Listing:

Shares of Stallion India Fluorochemicals was locked in upper circuit of 5% at Rs 125.99 at 10:22 IST on the BSE, representing a premium of 39.99% as compared with the issue price of Rs 90.

The scrip was listed at Rs 120, exhibiting a premium of 33.33% to the issue price.

So far, the stock has hit a high of 125.99 and a low of 120. On the BSE, over 7.27 lakh shares of the company were traded in the counter so far

Buzzing Index:

The Nifty IT index jumped 2.18% to 43,517.05. The index rallied 4.36% in two consecutive trading sessions.

Coforge (up 10.78%), Persistent Systems (up 9.41%), Wipro (up 4.59%), Mphasis (up 3.31%), LTIMindtree (up 2.76%), Tech Mahindra (up 1.81%), L&T Technology Services (up 1.68%), Infosys (up 0.62%) and Tata Consultancy Services (up 0.51%) advanced.

Persistent Systems surged 9.41% after the company’s consolidated net profit jumped 14.77% to Rs 372.99 crore in Q3 FY25 as compared with Rs 325 crore in Q2 FY25. Revenue from operations increased 5.7% QoQ to Rs 3,062.28 crore in Q3 FY25.

Stocks in Spotlight:

Laxmi Organic Industries rallied 4.20% after the company’s consolidated net profit jumped 7.76% to Rs 29.30 crore in Q3 FY25 as against Rs 27.18 crore reported in Q3 FY24. Revenue from operations stood at Rs 786.34 crore in Q3 FY25, marking a growth of 13.25% from Rs 694.30 crore recorded in the corresponding quarter last year.

Piramal Pharma advanced 2.02% after the company said that its subsidiary Piramal Critical Care (PCC) has launched Chlorpromazine Hydrochloride for Injection in various strengths in the US market.

Powered by Capital Market - Live News

Revenue from operations stood at Rs 786.34 crore in Q3 FY25, marking a growth of 13.25% from Rs 694.30 crore recorded in the corresponding quarter last year.

Profit before tax surged 59.22% year on year to Rs 47.05 crore in the quarter ended 31 December 2024.

EBITDA jumped 43.02% to Rs 74.80 crore in Q3 FY25 from Rs 52.30 crore posted in Q3 FY24. EBITDA margin advanced to 9.5% in Q3 FY25 as compared with 7.55% reported in the corresponding quarter previous year.

On a nine-month basis, the company's net profit rose 20.34% to Rs 91.74 crore on 9.63% increase in revenue to Rs 2,275.8 crore in 9M FY25 over 9M FY24.

Dr. Rajan Venkatesh, MD and CEO, Laxmi Organic Industries, said, “We have continued our growth journey and delivered double-digit growth in volumes, revenue, and EBITDA in Q3 & 9MFY25 on a year-on-year basis, despite the prevailing operating environment and the constantly evolving geopolitical backdrop and its consequences.

This growth continues to be driven by our focus on: a) operational efficiency efforts resulting in both additional volumes and improved cost competitiveness; b) capacity augmentation; and c) our customer-centric approach, which has enabled us to expand our market share and widen our reach to new customers & industries.

At our Fluoro-intermediates site, we are steadily changing gears and are now focused on generating revenues from Q4 FY25 to expand our overall Specialties intermediate product offerings to our customers.

At our Dahej site, we continue to remain on track to receive the pending regulatory approvals, and the project remains on schedule on timelines and budget. We remain #GearedtoWin and #GearedforGrowth to achieve our laid-out plans for FY28. I would like to share my deep appreciation with the whole Laxmi Organic team, our customers, and all related stakeholders.”

Laxmi Organic Industries is a leading manufacturer of acetyl intermediates and specialty intermediates with almost three decades of experience in large-scale manufacturing of chemicals.

Powered by Capital Market - Live News

Net profit of Laxmi Organic Industries rose 7.80% to Rs 29.31 crore in the quarter ended December 2024 as against Rs 27.19 crore during the previous quarter ended December 2023. Sales rose 13.26% to Rs 786.34 crore in the quarter ended December 2024 as against Rs 694.30 crore during the previous quarter ended December 2023.

Powered by Capital Market - Live News

Revenue from operations stood at Rs 786.34 crore in Q3 FY25, marking a growth of 13.25% from Rs 694.30 crore recorded in the corresponding quarter last year.

Profit before tax surged 59.22% year on year to Rs 47.05 crore in the quarter ended 31 December 2024.

EBITDA jumped 43.02% to Rs 74.80 crore in Q3 FY25 from Rs 52.30 crore posted in Q3 FY24. EBITDA margin advanced to 9.5% in Q3 FY25 as compared with 7.55% reported in the corresponding quarter previous year.

On a nine-month basis, the company's net profit rose 20.34% to Rs 91.74 crore on 9.63% increase in revenue to Rs 2,275.8 crore in 9M FY25 over 9M FY24.

Dr. Rajan Venkatesh, MD and CEO, Laxmi Organic Industries, said, “We have continued our growth journey and delivered double-digit growth in volumes, revenue, and EBITDA in Q3 & 9MFY25 on a year-on-year basis, despite the prevailing operating environment and the constantly evolving geopolitical backdrop and its consequences.

This growth continues to be driven by our focus on: a) operational efficiency efforts resulting in both additional volumes and improved cost competitiveness; b) capacity augmentation; and c) our customer-centric approach, which has enabled us to expand our market share and widen our reach to new customers & industries.

At our Fluoro-intermediates site, we are steadily changing gears and are now focused on generating revenues from Q4 FY25 to expand our overall Specialties intermediate product offerings to our customers.

At our Dahej site, we continue to remain on track to receive the pending regulatory approvals, and the project remains on schedule on timelines and budget. We remain #GearedtoWin and #GearedforGrowth to achieve our laid-out plans for FY28. I would like to share my deep appreciation with the whole Laxmi Organic team, our customers, and all related stakeholders.”

Laxmi Organic Industries is a leading manufacturer of acetyl intermediates and specialty intermediates with almost three decades of experience in large-scale manufacturing of chemicals.

Powered by Capital Market - Live News

Net profit of Laxmi Organic Industries rose 7.80% to Rs 29.31 crore in the quarter ended December 2024 as against Rs 27.19 crore during the previous quarter ended December 2023. Sales rose 13.26% to Rs 786.34 crore in the quarter ended December 2024 as against Rs 694.30 crore during the previous quarter ended December 2023.

Powered by Capital Market - Live News

Laxmi Organic Industries will hold a meeting of the Board of Directors of the Company on 22 January 2025.

Powered by Capital Market - Live News

The headline equity benchmarks pared all early losses and traded with modest gains in morning trade. The Nifty traded above the 23,200 level after hitting the day's low of 23,090.65 in early trade. IT shares extended gains for the second consecutive trading session. Trading could be volatile due to weekly F&O series expiry today.

At 10:30 IST, the barometer index, the S&P BSE Sensex rose 235.91 points or 0.31% to 76,640.90. The Nifty 50 index added 82 points or 0.35% to 23,237.35.

The broader market outperformed the frontline indices. The S&P BSE Mid-Cap index jumped 1.96% and the S&P BSE Small-Cap index rallied 1.24%.

The market breadth was strong. On the BSE, 2,411 shares rose and 1,094 shares fell. A total of 174 shares were unchanged.

Politics:

The JD(U) on Wednesday sacked its Manipur unit president, Ksh. Biren Singh, in an effort to quell growing speculation about its ties with the BJP. Party’s national spokesperson Rajiv Ranjan told the media Singh’s removal was due to indiscipline and asserted that the party would continue to support the BJP-led government in the northeastern state. Ranjan affirmed that the JD(U) remains committed to supporting the BJP-led NDA, not just in Manipur but across the country. Ranjan’s remark came shorty after Ksh Biren Singh claimed that the party had withdrawn support to the BJP-led Biren Singh government and informed its decision to governor Ajay Kumar Bhalla. The state unit chief had also claimed that the lone JDU MLA in the state, Md Abdul Nasir, will sit in the opposition benches.

Result Today:

UltraTech Cement (up 1.70%), Dr Reddy's Laboratories (down 0.77%), Hindustan Petroleum Corporation (down 1.18%), Indus Towers (up 2.06%), United Spirits (up 2.03%), Adani Energy Solutions (up 0.23%), Adani Green Energy (up 1.32%), Amber Enterprises India (up 10.35%), Capri Global Capital (up 1.34%), Cyient (up 1.74%), Greaves Cotton (up 2.88%), Indian Energy Exchange (down 0.15%), KFin Technologies (up 4.99%), Mankind Pharma (up 1.33%), Mphasis (up 3.44%), Nippon Life India Asset Management (up 2.64%), Senores Pharmaceuticals (up 2.52%), Sona BLW Precision Forgings (up 2.05%), Spandana Sphoorty Financial (down 0.08%), Suryoday Small Finance Bank (up 1.82%), Syngene International (down 0.19%), Tejas Networks (up 1.40%), Thyrocare Technologies (up 1.87%), Ujjivan Small Finance Bank (up 0.84%), V2 Retail (up 3.26%) and Zee Entertainment Enterprises (up 1.44%) will announce their quarterly later today.

New Listing:

Shares of Stallion India Fluorochemicals was locked in upper circuit of 5% at Rs 125.99 at 10:22 IST on the BSE, representing a premium of 39.99% as compared with the issue price of Rs 90.

The scrip was listed at Rs 120, exhibiting a premium of 33.33% to the issue price.

So far, the stock has hit a high of 125.99 and a low of 120. On the BSE, over 7.27 lakh shares of the company were traded in the counter so far

Buzzing Index:

The Nifty IT index jumped 2.18% to 43,517.05. The index rallied 4.36% in two consecutive trading sessions.

Coforge (up 10.78%), Persistent Systems (up 9.41%), Wipro (up 4.59%), Mphasis (up 3.31%), LTIMindtree (up 2.76%), Tech Mahindra (up 1.81%), L&T Technology Services (up 1.68%), Infosys (up 0.62%) and Tata Consultancy Services (up 0.51%) advanced.

Persistent Systems surged 9.41% after the company’s consolidated net profit jumped 14.77% to Rs 372.99 crore in Q3 FY25 as compared with Rs 325 crore in Q2 FY25. Revenue from operations increased 5.7% QoQ to Rs 3,062.28 crore in Q3 FY25.

Stocks in Spotlight:

Laxmi Organic Industries rallied 4.20% after the company’s consolidated net profit jumped 7.76% to Rs 29.30 crore in Q3 FY25 as against Rs 27.18 crore reported in Q3 FY24. Revenue from operations stood at Rs 786.34 crore in Q3 FY25, marking a growth of 13.25% from Rs 694.30 crore recorded in the corresponding quarter last year.

Piramal Pharma advanced 2.02% after the company said that its subsidiary Piramal Critical Care (PCC) has launched Chlorpromazine Hydrochloride for Injection in various strengths in the US market.

Powered by Capital Market - Live News

Revenue from operations stood at Rs 786.34 crore in Q3 FY25, marking a growth of 13.25% from Rs 694.30 crore recorded in the corresponding quarter last year.

Profit before tax surged 59.22% year on year to Rs 47.05 crore in the quarter ended 31 December 2024.

EBITDA jumped 43.02% to Rs 74.80 crore in Q3 FY25 from Rs 52.30 crore posted in Q3 FY24. EBITDA margin advanced to 9.5% in Q3 FY25 as compared with 7.55% reported in the corresponding quarter previous year.

On a nine-month basis, the company's net profit rose 20.34% to Rs 91.74 crore on 9.63% increase in revenue to Rs 2,275.8 crore in 9M FY25 over 9M FY24.

Dr. Rajan Venkatesh, MD and CEO, Laxmi Organic Industries, said, “We have continued our growth journey and delivered double-digit growth in volumes, revenue, and EBITDA in Q3 & 9MFY25 on a year-on-year basis, despite the prevailing operating environment and the constantly evolving geopolitical backdrop and its consequences.

This growth continues to be driven by our focus on: a) operational efficiency efforts resulting in both additional volumes and improved cost competitiveness; b) capacity augmentation; and c) our customer-centric approach, which has enabled us to expand our market share and widen our reach to new customers & industries.

At our Fluoro-intermediates site, we are steadily changing gears and are now focused on generating revenues from Q4 FY25 to expand our overall Specialties intermediate product offerings to our customers.

At our Dahej site, we continue to remain on track to receive the pending regulatory approvals, and the project remains on schedule on timelines and budget. We remain #GearedtoWin and #GearedforGrowth to achieve our laid-out plans for FY28. I would like to share my deep appreciation with the whole Laxmi Organic team, our customers, and all related stakeholders.”

Laxmi Organic Industries is a leading manufacturer of acetyl intermediates and specialty intermediates with almost three decades of experience in large-scale manufacturing of chemicals.

Powered by Capital Market - Live News

Net profit of Laxmi Organic Industries rose 7.80% to Rs 29.31 crore in the quarter ended December 2024 as against Rs 27.19 crore during the previous quarter ended December 2023. Sales rose 13.26% to Rs 786.34 crore in the quarter ended December 2024 as against Rs 694.30 crore during the previous quarter ended December 2023.

Powered by Capital Market - Live News

Revenue from operations stood at Rs 786.34 crore in Q3 FY25, marking a growth of 13.25% from Rs 694.30 crore recorded in the corresponding quarter last year.

Profit before tax surged 59.22% year on year to Rs 47.05 crore in the quarter ended 31 December 2024.

EBITDA jumped 43.02% to Rs 74.80 crore in Q3 FY25 from Rs 52.30 crore posted in Q3 FY24. EBITDA margin advanced to 9.5% in Q3 FY25 as compared with 7.55% reported in the corresponding quarter previous year.

On a nine-month basis, the company's net profit rose 20.34% to Rs 91.74 crore on 9.63% increase in revenue to Rs 2,275.8 crore in 9M FY25 over 9M FY24.

Dr. Rajan Venkatesh, MD and CEO, Laxmi Organic Industries, said, “We have continued our growth journey and delivered double-digit growth in volumes, revenue, and EBITDA in Q3 & 9MFY25 on a year-on-year basis, despite the prevailing operating environment and the constantly evolving geopolitical backdrop and its consequences.

This growth continues to be driven by our focus on: a) operational efficiency efforts resulting in both additional volumes and improved cost competitiveness; b) capacity augmentation; and c) our customer-centric approach, which has enabled us to expand our market share and widen our reach to new customers & industries.

At our Fluoro-intermediates site, we are steadily changing gears and are now focused on generating revenues from Q4 FY25 to expand our overall Specialties intermediate product offerings to our customers.

At our Dahej site, we continue to remain on track to receive the pending regulatory approvals, and the project remains on schedule on timelines and budget. We remain #GearedtoWin and #GearedforGrowth to achieve our laid-out plans for FY28. I would like to share my deep appreciation with the whole Laxmi Organic team, our customers, and all related stakeholders.”

Laxmi Organic Industries is a leading manufacturer of acetyl intermediates and specialty intermediates with almost three decades of experience in large-scale manufacturing of chemicals.

Powered by Capital Market - Live News

Net profit of Laxmi Organic Industries rose 7.80% to Rs 29.31 crore in the quarter ended December 2024 as against Rs 27.19 crore during the previous quarter ended December 2023. Sales rose 13.26% to Rs 786.34 crore in the quarter ended December 2024 as against Rs 694.30 crore during the previous quarter ended December 2023.

Powered by Capital Market - Live News

Laxmi Organic Industries will hold a meeting of the Board of Directors of the Company on 22 January 2025.

Powered by Capital Market - Live News